- Multiple daily “spaced” tDCS stimulation sessions over 2 weeks helped patients with major depression in reported research.1
- The protocol informs dosing and trial design for transcranial stimulation in neuromodulation pipelines (Brain and Behavior Research Foundation).1 1
Gardner updates
- Multiple daily ‘spaced’ tDCS stimulation sessions over 2 weeks helped patients with major depression, informing dosing and trial design for transcranial stimulation (Brain and Behavior Research Foundation). 1
Weekly enrichment (2026-07-20)
- This was the first clinical test of “spaced” tDCS for major depression: a prospective, open-label study enrolling 30 participants with MDD, of whom 28 were analyzed.23
- The protocol delivered 5 tDCS sessions per day on weekdays over 2 consecutive weeks — 50 sessions total — with each 20-minute session separated by 20-minute inter-session intervals (roughly 3 hours of treatment per day).23
- HAM-D-17 (HDRS-17) scores fell from a mean of 21.3 at baseline to 15.3 at 1 week and 13.2 at 4 weeks post-treatment, a significant effect of time (repeated-measures ANOVA F(2,52)=29.131, p<.001, partial η²=.528); MADRS followed a similar trajectory.23
- Response (≥50% symptom reduction) rose from 21.4% at 1 week to 46.4% at 4 weeks, and remission from 10.7% to 32.1%, indicating a delayed, growing antidepressant benefit after treatment ended.23
- Remission was defined as HDRS-17 ≤7 and MADRS ≤10, with response defined as ≥50% reduction from baseline and remitters always counted as responders.3
- Feasibility metrics were strong: a 93.3% retention rate, 99.7% session adherence, and no serious adverse events.3
- Side effects were mild — tingling/itching during stimulation (100%) and temporary skin redness afterward (100%); 64.3% developed mild irritative contact dermatitis that resolved by the 4-week follow-up and was not treatment-limiting.3
- The spaced schedule is hypothesized to engage neuroplasticity (late long-term potentiation, l-LTP) more effectively than standard once-daily tDCS; the authors call for sham-controlled trials and DLPFC-targeted protocols to confirm efficacy.23
Footnotes
-
https://news.google.com/rss/articles/CBMitwFBVV95cUxNZ251UTZoVHhEc09QX2tHVGQwUTdVUmFjV2x6TmN1NEo0Rm9IdU4xUEhhZHE0QzdEb2liWWJaZThqSUJpZkwxbWNiZC1kNlFPYjBnYk1hZ241QXJHSU50U3ppc2tMVDluOE8yU0dYVURWazNDWHVLbDFia0hNRHVpSGtZM1ZDWDc5U0t1QTltTTZ3OTc2NElNaW9Qc3kzYVY2VjZJekdzTWlrWlRZeTJhRm5SQ2JEczA?oc=5 ↩ ↩2 ↩3 ↩4
-
https://bbrfoundation.org/content/multiple-daily-spaced-tdcs-stimulation-sessions-over-2-weeks-helped-patients-major ↩ ↩2 ↩3 ↩4 ↩5
-
https://doi.org/10.1016/j.brs.2025.05.079 ↩ ↩2 ↩3 ↩4 ↩5 ↩6 ↩7 ↩8